相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit
Nidhi Gera et al.
PLOS ONE (2015)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
INTERIM ANALYSIS OF THE EF-14 TRIAL: A PROSPECTIVE, MULTI-CENTER TRIAL OF NOVOTTF-100A TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GBM
Roger Stupp et al.
NEURO-ONCOLOGY (2014)
Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma
Eric T. Wong et al.
CANCER MEDICINE (2014)
Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
Alice Hervieu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group
Sun-Ho Lee et al.
NEURO-ONCOLOGY (2013)
Immunosurveillance as a regulator of tissue homeostasis
Laura Senovilla et al.
TRENDS IN IMMUNOLOGY (2013)
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients
D. A. Reardon et al.
BRITISH JOURNAL OF CANCER (2012)
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
Kan V. Lu et al.
CANCER CELL (2012)
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp et al.
EUROPEAN JOURNAL OF CANCER (2012)
NovoTTF-100A: a new treatment modality for recurrent glioblastoma
Ekokobe Fonkem et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Kim Margolin et al.
LANCET ONCOLOGY (2012)
The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy
Andy K. Hsu et al.
BLOOD (2011)
Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2011)
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
Baisakhi Raychaudhuri et al.
NEURO-ONCOLOGY (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Prognostic significance and mechanism of Treg infiltration in human brain tumors
Joannes F. M. Jacobs et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
A. D. Norden et al.
NEUROLOGY (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors
Eilon D. Kirson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
PE Fecci et al.
CANCER RESEARCH (2006)
Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection
MA Hughes et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Disruption of cancer cell replication by alternating electric fields
ED Kirson et al.
CANCER RESEARCH (2004)
Alkylating DNA damage stimulates a regulated form of necrotic cell death
WX Zong et al.
GENES & DEVELOPMENT (2004)
分享论文
